About this trial
This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy while remaining simplistic for patients of varying levels of health care literacy. The investigative team will be focusing on urgent warning signs pertinent to the postpartum period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Postpartum women
Nulliparity
Age >18 years of age
English speaking patients
Disqualifiers
Inability to provide informed written consent
Refusal to participate in all study-related procedures
Patients not fluent in English
Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
Trial design
Parallel
Treatments tested in this trial
Participant will view a visual aid picture (appendix A) first
Other interventionParticipant will view a visual aid picture (appendix A) of a post delivery complication first
Participant will view a visual aid picture (appendix B) first
Other interventionParticipant will view a visual aid picture (appendix B) of a post delivery complication first
Treatment groups
Trial outcomes
Primary outcomes
Number of participants who recognize deep vein thrombosis,
Participant will accurately identify the health care issue shown to participants and identified as Picture A and Picture B
Secondary outcomes
Number of participants who demonstrate understanding deep vein thrombosis,
Participants written response of the understanding of deep vein thrombosis.
Number of participants who would report deep vein thrombosis
After review of Picture A and Picture B number of participants who report deep vein thrombosis to their care provider or emergency room.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.